-
Je něco špatně v tomto záznamu ?
An Assay of Selected Serum Amino Acids in Patients with Type 2 Diabetes Mellitus
P. Drábková, J. Šanderová, J. Kovařík, R. kanďár,
Jazyk angličtina Země Polsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 2006
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
26467133
DOI
10.17219/acem/29223
Knihovny.cz E-zdroje
- MeSH
- aminokyseliny krev MeSH
- biologické markery krev MeSH
- chromatografie iontoměničová MeSH
- diabetes mellitus 2. typu krev diagnóza MeSH
- fluorescenční spektrometrie MeSH
- glykovaný hemoglobin analýza MeSH
- krevní glukóza analýza MeSH
- laboratorní automatizace MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- studie případů a kontrol MeSH
- vysokoúčinná kapalinová chromatografie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Amino acids are the building blocks of proteins. In case of insulin resistance, which is typical for type 2 diabetes mellitus (T2DM), proteolysis is increased and protein synthesis is decreased; therefore, we can observe changes in the levels of amino acids in diabetics vs. non-diabetics. OBJECTIVES: The aim of this study was to find differences in the levels of selected amino acids between patients with diabetes (type 2) and a control group. MATERIAL AND METHODS: Amino acids were derivatized with naphthalene-2,3-dicarboxaldehyde in the presence of potassium cyanide to form fluorescent 1-cyanobenz(f)isoindole product. Amino acids derivatives were measured using a high-performance liquid chromatography with fluorescence detection. The serum levels of glucose were determined using an automatic biochemistry analyzer, glycated hemoglobin HbA1c was measured by cation exchange chromatography. RESULTS: A total of 19 serum amino acids in T2DM patients and non-diabetics were measured. There were 9 amino acids, which were significantly different in these groups (p<0.05). Significantly decreased levels of arginine, asparagine, glycine, serine, threonine and significantly increased levels of alanine, isoleucine, leucine, valine in diabetics were found. CONCLUSIONS: Significant difference in metabolism of amino acids between diabetics and non-diabetics were observed. The altered levels of amino acids in diabetic patients could be a suitable predictor of diabetes.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16000011
- 003
- CZ-PrNML
- 005
- 20200121083425.0
- 007
- ta
- 008
- 160108s2015 pl f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.17219/acem/29223 $2 doi
- 035 __
- $a (PubMed)26467133
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a pl
- 100 1_
- $a Drábková, Petra $u Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Czech Republic.
- 245 13
- $a An Assay of Selected Serum Amino Acids in Patients with Type 2 Diabetes Mellitus / $c P. Drábková, J. Šanderová, J. Kovařík, R. kanďár,
- 520 9_
- $a BACKGROUND: Amino acids are the building blocks of proteins. In case of insulin resistance, which is typical for type 2 diabetes mellitus (T2DM), proteolysis is increased and protein synthesis is decreased; therefore, we can observe changes in the levels of amino acids in diabetics vs. non-diabetics. OBJECTIVES: The aim of this study was to find differences in the levels of selected amino acids between patients with diabetes (type 2) and a control group. MATERIAL AND METHODS: Amino acids were derivatized with naphthalene-2,3-dicarboxaldehyde in the presence of potassium cyanide to form fluorescent 1-cyanobenz(f)isoindole product. Amino acids derivatives were measured using a high-performance liquid chromatography with fluorescence detection. The serum levels of glucose were determined using an automatic biochemistry analyzer, glycated hemoglobin HbA1c was measured by cation exchange chromatography. RESULTS: A total of 19 serum amino acids in T2DM patients and non-diabetics were measured. There were 9 amino acids, which were significantly different in these groups (p<0.05). Significantly decreased levels of arginine, asparagine, glycine, serine, threonine and significantly increased levels of alanine, isoleucine, leucine, valine in diabetics were found. CONCLUSIONS: Significant difference in metabolism of amino acids between diabetics and non-diabetics were observed. The altered levels of amino acids in diabetic patients could be a suitable predictor of diabetes.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a aminokyseliny $x krev $7 D000596
- 650 _2
- $a laboratorní automatizace $7 D057205
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a krevní glukóza $x analýza $7 D001786
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $7 D002851
- 650 _2
- $a chromatografie iontoměničová $7 D002852
- 650 _2
- $a diabetes mellitus 2. typu $x krev $x diagnóza $7 D003924
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a glykovaný hemoglobin $x analýza $7 D006442
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a fluorescenční spektrometrie $7 D013050
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Šanderová, Jana $u Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Czech Republic.
- 700 1_
- $a Kovařík, Jakub $u Department of Clinical Biochemistry and Diagnostics, Faculty of Chemical Technology, Regional Hospital Pardubice, Czech Republic.
- 700 1_
- $a kanďár, Roman $u Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Czech Republic.
- 773 0_
- $w MED00187101 $t Advances in clinical and experimental medicine official organ Wroclaw Medical University $x 1899-5276 $g Roč. 24, č. 3 (2015), s. 447-51
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26467133 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160108 $b ABA008
- 991 __
- $a 20200121083802 $b ABA008
- 999 __
- $a ok $b bmc $g 1102292 $s 924217
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 24 $c 3 $d 447-51 $i 1899-5276 $m Advances in clinical and experimental medicine $n Adv Clin Exp Med $x MED00187101
- LZP __
- $a Pubmed-20160108